Clinical Trial Update: Conversion From Tacrolimus to Cyclosporine Microemulsion in Liver Transplant Patients With New Onset Diabetes After the 3rd Month Post-transplant [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating conversion from tacrolimus to cyclosporine microemulsion in maintenance liver transplant patients who developed new-onset diabetes afte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• New-onset Diabetes After Transplantation

Drugs mentioned

• Neoral (Cyclosporine microemulsion) (Cyclosporine)
• Prograf (Tacrolimus) (Tacrolimus)

Snippet

Sponsor: Novartis | Conditions: Maintenance Liver Transplant Patients With New Onset Diabetes | Phase 4 | Status: COMPLETED